A 2014 study of 224 case subjects measured levels of IGF-I, IGF-II, and IGFBPs 1-7 and found that IGFBP-5 and IGF-II levels were higher in benign tumors than in NSCLC [60]. Here, IGF1 is linked to non-small cell lung carcinoma.